JP Stock MarketDetailed Quotes

4583 Chiome Bioscience

Watchlist
  • 265
  • +6+2.32%
20min DelayMarket Closed Dec 27 15:30 JST
17.31BMarket Cap-10.76P/E (Static)

Chiome Bioscience Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
-29.24%134.08M
-23.47%129.64M
8.19%682.46M
-19.62%158.44M
6.21%165.13M
26.63%189.49M
31.76%169.4M
-11.52%630.82M
15.11%197.12M
-0.81%155.48M
Cost of revenue
-26.61%56.33M
-1.11%72.65M
0.68%283.87M
-19.60%66.94M
-6.84%66.72M
10.66%76.75M
27.25%73.46M
-2.93%281.96M
-3.84%83.25M
-7.95%71.62M
Gross profit
-31.03%77.76M
-40.59%57M
14.26%398.6M
-19.64%91.5M
17.35%98.41M
40.41%112.74M
35.43%95.94M
-17.42%348.86M
34.49%113.87M
6.22%83.86M
Operating expense
-38.33%336.74M
17.77%379.15M
-0.23%1.6B
17.46%391.36M
0.15%344.48M
46.38%545.99M
-42.24%321.93M
-8.50%1.61B
-41.36%333.19M
-33.12%343.97M
Research and development costs
-50.91%200.41M
27.25%246.41M
-7.37%1.05B
13.44%248.66M
-10.69%201.35M
66.65%408.26M
-56.58%193.64M
-13.46%1.14B
-51.49%219.2M
-43.77%225.44M
Other operating expenses
-1.02%136.33M
3.47%132.75M
16.94%551.86M
25.18%142.7M
20.75%143.13M
7.59%137.73M
15.21%128.3M
6.14%471.9M
-2.02%114M
4.51%118.54M
Operating profit
40.22%-258.98M
-42.55%-322.16M
4.25%-1.21B
-36.72%-299.86M
5.40%-246.06M
-48.02%-433.26M
53.55%-225.99M
5.67%-1.26B
54.65%-219.33M
40.26%-260.11M
Net non-operating interest income (expenses)
-120.28%-1.4M
-54.90%-1.87M
-157.01%-12.51M
-2.65%-1.55M
-598.93%-9.11M
-14.80%-636K
19.52%-1.2M
40.94%-4.87M
77.36%-1.51M
-267.32%-1.3M
Non-operating interest income
600.00%14K
-25.00%6K
-9.52%19K
0.00%2K
-12.50%7K
100.00%2K
-20.00%8K
-27.59%21K
0.00%2K
-33.33%8K
Non-operating interest expense
24.61%714K
68.55%568K
56.39%2.07M
71.43%588K
70.45%571K
76.85%573K
4.98%337K
0.53%1.32M
0.00%343K
-0.59%335K
Total other finance cost
978.46%701K
48.91%1.3M
193.38%10.46M
-17.51%966K
775.13%8.55M
-71.86%65K
-26.16%875K
-48.73%3.56M
-81.52%1.17M
3,156.67%977K
Net investment income
94.44%-48K
930.91%567K
190.16%513K
-89.31%262K
231.97%1.06M
-429.45%-863K
101.73%55K
-108.59%-569K
847.26%2.45M
72.43%319K
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
7,628.57%1.05M
-75.27%248K
-62.66%2.23M
701K
-90.64%542K
-107.53%-14K
1M
-53.71%5.98M
0
1,460.92%5.79M
Less:Other special charges
-7,628.57%-1.05M
75.27%-248K
62.66%-2.23M
---701K
90.64%-542K
--14K
---1M
53.71%-5.98M
--0
-1,460.92%-5.79M
Other non-operating income (expenses)
106.00%103K
7,145.86%20.43M
-100.39%-79K
-96.67%144K
240.00%17K
-99.69%50K
-5,900.00%-290K
206.00%20.25M
1.05%4.33M
-99.74%5K
Income before tax
40.36%-259.27M
-33.72%-302.77M
1.85%-1.22B
-40.29%-300.3M
0.68%-253.56M
-56.76%-434.72M
53.90%-226.43M
15.59%-1.24B
66.36%-214.06M
41.07%-255.3M
Income tax
-47.09%663K
0.00%1.25M
0.00%5.01M
0.00%1.25M
0.00%1.25M
0.00%1.25M
0.00%1.25M
-62.87%5.01M
54.69%1.25M
54.57%1.25M
Net income
40.38%-259.93M
-33.53%-304.02M
1.84%-1.22B
-40.05%-301.55M
0.68%-254.81M
-56.51%-435.97M
53.76%-227.68M
16.02%-1.24B
66.20%-215.31M
40.89%-256.55M
Net income continuous operations
40.38%-259.94M
-33.53%-304.02M
1.84%-1.22B
-40.05%-301.55M
0.68%-254.81M
-56.51%-435.97M
53.76%-227.68M
16.02%-1.24B
66.20%-215.31M
40.89%-256.55M
Noncontrolling interests
Net income attributable to the company
40.38%-259.93M
-33.53%-304.02M
1.84%-1.22B
-40.05%-301.55M
0.68%-254.81M
-56.51%-435.97M
53.76%-227.68M
16.02%-1.24B
66.20%-215.31M
40.89%-256.55M
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
40.38%-259.93M
-33.53%-304.02M
1.84%-1.22B
-40.05%-301.55M
0.68%-254.81M
-56.51%-435.97M
53.76%-227.68M
16.02%-1.24B
66.20%-215.31M
40.89%-256.55M
Gross dividend payment
Basic earnings per share
48.78%-4.61
-19.15%-5.6
12.88%-24.62
-32.12%-5.8
10.18%-5.12
-38.25%-9
59.69%-4.7
23.08%-28.26
72.22%-4.39
47.12%-5.7
Diluted earnings per share
48.77%-4.6103
-19.15%-5.6
12.88%-24.62
-30.44%-5.8
10.18%-5.12
-38.25%-9
59.69%-4.7
23.08%-28.26
71.86%-4.4465
47.12%-5.7
Dividend per share
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue -29.24%134.08M-23.47%129.64M8.19%682.46M-19.62%158.44M6.21%165.13M26.63%189.49M31.76%169.4M-11.52%630.82M15.11%197.12M-0.81%155.48M
Cost of revenue -26.61%56.33M-1.11%72.65M0.68%283.87M-19.60%66.94M-6.84%66.72M10.66%76.75M27.25%73.46M-2.93%281.96M-3.84%83.25M-7.95%71.62M
Gross profit -31.03%77.76M-40.59%57M14.26%398.6M-19.64%91.5M17.35%98.41M40.41%112.74M35.43%95.94M-17.42%348.86M34.49%113.87M6.22%83.86M
Operating expense -38.33%336.74M17.77%379.15M-0.23%1.6B17.46%391.36M0.15%344.48M46.38%545.99M-42.24%321.93M-8.50%1.61B-41.36%333.19M-33.12%343.97M
Research and development costs -50.91%200.41M27.25%246.41M-7.37%1.05B13.44%248.66M-10.69%201.35M66.65%408.26M-56.58%193.64M-13.46%1.14B-51.49%219.2M-43.77%225.44M
Other operating expenses -1.02%136.33M3.47%132.75M16.94%551.86M25.18%142.7M20.75%143.13M7.59%137.73M15.21%128.3M6.14%471.9M-2.02%114M4.51%118.54M
Operating profit 40.22%-258.98M-42.55%-322.16M4.25%-1.21B-36.72%-299.86M5.40%-246.06M-48.02%-433.26M53.55%-225.99M5.67%-1.26B54.65%-219.33M40.26%-260.11M
Net non-operating interest income (expenses) -120.28%-1.4M-54.90%-1.87M-157.01%-12.51M-2.65%-1.55M-598.93%-9.11M-14.80%-636K19.52%-1.2M40.94%-4.87M77.36%-1.51M-267.32%-1.3M
Non-operating interest income 600.00%14K-25.00%6K-9.52%19K0.00%2K-12.50%7K100.00%2K-20.00%8K-27.59%21K0.00%2K-33.33%8K
Non-operating interest expense 24.61%714K68.55%568K56.39%2.07M71.43%588K70.45%571K76.85%573K4.98%337K0.53%1.32M0.00%343K-0.59%335K
Total other finance cost 978.46%701K48.91%1.3M193.38%10.46M-17.51%966K775.13%8.55M-71.86%65K-26.16%875K-48.73%3.56M-81.52%1.17M3,156.67%977K
Net investment income 94.44%-48K930.91%567K190.16%513K-89.31%262K231.97%1.06M-429.45%-863K101.73%55K-108.59%-569K847.26%2.45M72.43%319K
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges) 7,628.57%1.05M-75.27%248K-62.66%2.23M701K-90.64%542K-107.53%-14K1M-53.71%5.98M01,460.92%5.79M
Less:Other special charges -7,628.57%-1.05M75.27%-248K62.66%-2.23M---701K90.64%-542K--14K---1M53.71%-5.98M--0-1,460.92%-5.79M
Other non-operating income (expenses) 106.00%103K7,145.86%20.43M-100.39%-79K-96.67%144K240.00%17K-99.69%50K-5,900.00%-290K206.00%20.25M1.05%4.33M-99.74%5K
Income before tax 40.36%-259.27M-33.72%-302.77M1.85%-1.22B-40.29%-300.3M0.68%-253.56M-56.76%-434.72M53.90%-226.43M15.59%-1.24B66.36%-214.06M41.07%-255.3M
Income tax -47.09%663K0.00%1.25M0.00%5.01M0.00%1.25M0.00%1.25M0.00%1.25M0.00%1.25M-62.87%5.01M54.69%1.25M54.57%1.25M
Net income 40.38%-259.93M-33.53%-304.02M1.84%-1.22B-40.05%-301.55M0.68%-254.81M-56.51%-435.97M53.76%-227.68M16.02%-1.24B66.20%-215.31M40.89%-256.55M
Net income continuous operations 40.38%-259.94M-33.53%-304.02M1.84%-1.22B-40.05%-301.55M0.68%-254.81M-56.51%-435.97M53.76%-227.68M16.02%-1.24B66.20%-215.31M40.89%-256.55M
Noncontrolling interests
Net income attributable to the company 40.38%-259.93M-33.53%-304.02M1.84%-1.22B-40.05%-301.55M0.68%-254.81M-56.51%-435.97M53.76%-227.68M16.02%-1.24B66.20%-215.31M40.89%-256.55M
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders 40.38%-259.93M-33.53%-304.02M1.84%-1.22B-40.05%-301.55M0.68%-254.81M-56.51%-435.97M53.76%-227.68M16.02%-1.24B66.20%-215.31M40.89%-256.55M
Gross dividend payment
Basic earnings per share 48.78%-4.61-19.15%-5.612.88%-24.62-32.12%-5.810.18%-5.12-38.25%-959.69%-4.723.08%-28.2672.22%-4.3947.12%-5.7
Diluted earnings per share 48.77%-4.6103-19.15%-5.612.88%-24.62-30.44%-5.810.18%-5.12-38.25%-959.69%-4.723.08%-28.2671.86%-4.446547.12%-5.7
Dividend per share
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Top JP Stock Gainers
Symbol Price % Chg
Twenty-four seven
7074
290 +33.64%
Alpico Holdings
297A
321 +33.20%
Branding Technology
7067
1338 +28.90%
Estore
4304
1504 +24.92%
Axel Mark
3624
172 +22.86%

See the daily top gainer.